BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35472336)

  • 1. Screening of genes related to breast cancer prognosis based on the DO-UniBIC method.
    Zhang F; Zhang Y; Hou T; Ren F; Liu X; Zhao R; Zhang X
    Am J Med Sci; 2022 Sep; 364(3):333-342. PubMed ID: 35472336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models.
    Li L; Liu ZP
    J Transl Med; 2021 Dec; 19(1):514. PubMed ID: 34930307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of Prognostic Factors in Early-Onset Breast Cancer.
    Yu Z; He Q; Xu G
    Technol Cancer Res Treat; 2020; 19():1533033819893670. PubMed ID: 32028860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    Mo W; Ding Y; Zhao S; Zou D; Ding X
    PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer.
    Zhao X; Lin J
    Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
    Wu J; Zhang Y; Li M
    J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system.
    Xiao B; Hang J; Lei T; He Y; Kuang Z; Wang L; Chen L; He J; Zhang W; Liao Y; Sun Z; Li L
    Mol Biol Rep; 2019 Apr; 46(2):2111-2119. PubMed ID: 30888555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differentially expressed genes-related prognostic risk model for survival prediction in breast carcinoma patients.
    Li J; Huang G; Ren C; Wang N; Sui S; Zhao Z; Li M
    Aging (Albany NY); 2021 Jun; 13(12):16577-16599. PubMed ID: 34175839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
    Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
    JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of prognostic biomarkers for breast cancer based on miRNA and mRNA co-expression network.
    Yao Y; Liu R; Gao C; Zhang T; Qi L; Liu G; Zhang W; Wang X; Li J; Li J; Sun C
    J Cell Biochem; 2019 Sep; 120(9):15378-15388. PubMed ID: 31037764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key Genes and Prognostic Analysis in HER2+ Breast Cancer.
    Weng Y; Liang W; Ji Y; Li Z; Jia R; Liang Y; Ning P; Xu Y
    Technol Cancer Res Treat; 2021; 20():1533033820983298. PubMed ID: 33499770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
    BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of Prognosis-Related Genes in Primary Breast Carcinoma Using Genomic Expression Data.
    Gu Y; Chen G; Du Y
    J Comput Biol; 2020 Jul; 27(7):1030-1040. PubMed ID: 31718274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico screening using bulk and single-cell RNA-seq data identifies RIMS2 as a prognostic marker in basal-like breast cancer: A retrospective study.
    Zhang L; Liu Z; Zhu J
    Medicine (Baltimore); 2021 Apr; 100(16):e25414. PubMed ID: 33879671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better Prognosis.
    Nie Y; Huang F; Lou L; Yan J
    Med Sci Monit; 2022 Feb; 28():e934424. PubMed ID: 35184130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immune-related risk gene signature predicts the prognosis of breast cancer.
    Cao W; Jiang Y; Ji X; Ma L
    Breast Cancer; 2021 May; 28(3):653-663. PubMed ID: 33400208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer.
    Tao C; Luo R; Song J; Zhang W; Ran L
    J Cell Biochem; 2020 Mar; 121(3):2385-2393. PubMed ID: 31646666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
    J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of breast cancer cell types and their prognostic power in breast cancer patients.
    Wang F; Dohogne Z; Yang J; Liu Y; Soibam B
    BMC Genomics; 2018 Feb; 19(1):137. PubMed ID: 29433432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.